Delivery Order SPE2DB22D2007-SPE2DB24FJ3QF
Award Date
6/24/24
Potential Completion Date
7/16/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug IBRANCE 125 MG CAPSULE 21S. The $7,792.08 firm fixed-price contract was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, and has an ultimate completion date of July 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $7,792.08 and a period of performance through May 13, 2024. The contract was awarded on April 22, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is a major pharmaceutical distribution company that holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $7,792.08 delivery order is for the supply of 4565844290 units of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG TABLET 7S. The contract has a ceiling value of $7,792.08 and an ultimate completion date of August 1, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed-price basis. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,592.62, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $8,061.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through January 27, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,236.16 firm fixed-price delivery order is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,736,132 units of the prescription medication IBRANCE 125 MG CAPSULE 21S, with a ceiling value of $7,792.08. The contract has a firm fixed price pricing type and a completion date of September 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,118.08 firm fixed-price contract is for the supply of IBRANCE 125 MG CAPSULE 21S, with a period of performance through April 1, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S to DLA. It is a firm-fixed price, delivery order contract with a completion date of May 10, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite...